Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Robbers Cave04:49

Robbers Cave

13.6K
During the 1950s, the landmark Robbers Cave experiment demonstrated that when groups must compete with one another, intergroup conflict, hostility, and even violence may result. At the Oklahoman summer camp, two troops of boys—termed the Rattlers and the Eagles—took part in a week-long tournament. During this time, their negativity culminated in derogatory name-calling, fistfights, and even vandalism and destruction of property. However, this work also revealed that such tension...
13.6K
Naturalistic Observations02:30

Naturalistic Observations

15.2K
If you want to understand how behavior occurs, one of the best ways to gain information is to simply observe the behavior in its natural context. However, people might change their behavior in unexpected ways if they know they are being observed. How do researchers obtain accurate information when people tend to hide their natural behavior? As an example, imagine that your professor asks everyone in your class to raise their hand if they always wash their hands after using the restroom. Chances...
15.2K
The Stanford Prison Experiment03:20

The Stanford Prison Experiment

22.4K
The famous and controversial Stanford Prison Experiment, conducted by social psychologist Philip Zimbardo and his colleagues at Stanford University, demonstrated the power of social roles, social norms, and scripts.
22.4K
Case Studies01:22

Case Studies

11.3K
There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
11.3K
Blinding01:11

Blinding

2.9K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.9K
Ethics in Research01:56

Ethics in Research

23.7K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
23.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of fibrate treatment in dyslipidemia: an overview.

Current pharmaceutical design·2013
Same author

Ezetimibe therapy for dyslipidemia: an update.

Current pharmaceutical design·2013
Same author

Hydrochlorothiazide vs. chlorthalidone as the optimal diuretic for the management of hypertension.

Current pharmaceutical design·2013
Same author

PCSK9 inhibition - a novel mechanism to treat lipid disorders?

Current pharmaceutical design·2013
Same author

Combined dyslipidemia: should the focus be LDL cholesterol or atherogenic dyslipidemia?

Current pharmaceutical design·2013
Same author

Achieving current goals in prevention and treatment of vascular disease: an update.

Current pharmaceutical design·2013
Same journal

Pharmacotherapeutic interventions for pediatric ulcerative colitis.

Expert opinion on pharmacotherapy·2026
Same journal

The rise and fall of TRPV1-targeted analgesia in osteoarthritis: a critical appraisal.

Expert opinion on pharmacotherapy·2026
Same journal

Dopamine transporter and beyond: evolving targets and combination strategies in stimulant use disorder.

Expert opinion on pharmacotherapy·2026
Same journal

GnRH antagonists for the treatment of fibroids and adenomyosis, current evidence and future perspectives.

Expert opinion on pharmacotherapy·2026
Same journal

Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia.

Expert opinion on pharmacotherapy·2026
Same journal

Current advances in pharmacotherapeutic strategies for the treatment of complicated intra-abdominal infections.

Expert opinion on pharmacotherapy·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

6.3K

Summarizing the FIELD study: lessons from a 'negative' trial.

Vasilis Tsimihodimos1, Dimitri P Mikhailidis, Moses Elisaf

  • 1University of Ioannina Medical School , 45 110 Ioannina , Greece +302651007362 ; +302651007016 ; vtsimi@cc.uoi.gr.

Expert Opinion on Pharmacotherapy
|November 12, 2013
PubMed
Summary
This summary is machine-generated.

Fenofibrate may help treat diabetic dyslipidemia and cardiovascular risk in diabetic patients. The FIELD study explored its effects, showing potential benefits for microvascular protection.

More Related Videos

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

3.3K
An Experimental Analysis of Children's Ability to Provide a False Report about a Crime
07:36

An Experimental Analysis of Children's Ability to Provide a False Report about a Crime

Published on: May 3, 2016

7.8K

Related Experiment Videos

Last Updated: May 6, 2026

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

6.3K
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

3.3K
An Experimental Analysis of Children's Ability to Provide a False Report about a Crime
07:36

An Experimental Analysis of Children's Ability to Provide a False Report about a Crime

Published on: May 3, 2016

7.8K

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Metabolic Disorders

Background:

  • Lipid metabolism disturbances are key in dysglycemic states, increasing diabetic complication risk.
  • Fibrates are theoretically ideal for diabetic dyslipidemia, but clinical evidence was limited.
  • The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study investigated fenofibrate's efficacy.

Purpose of the Study:

  • To summarize the findings of the FIELD trial regarding fenofibrate in diabetic patients.
  • To assess fenofibrate's role in managing diabetic dyslipidemia and cardiovascular risk.

Main Methods:

  • A double-blind, placebo-controlled trial.
  • Randomized 9795 diabetic subjects to fenofibrate or placebo.
  • Follow-up duration averaged 5 years.

Main Results:

  • Chronic kidney disease and metabolic syndrome significantly elevate cardiovascular risk in diabetics.
  • Fenofibrate demonstrated potential as a therapeutic option for atherogenic dyslipidemia.
  • The study highlighted fenofibrate's unique microvascular-protecting properties.

Conclusions:

  • Fenofibrate may be a valuable treatment for diabetic dyslipidemia.
  • Consideration of fenofibrate is warranted for its cardiovascular and microvascular benefits in diabetes.
  • Further research into fenofibrate's specific mechanisms for microvascular protection is suggested.